AC
Armistice Capital Portfolio holdings
AUM
$2.64B
This Quarter Return
-2.75%
1 Year Return
+0.99%
3 Year Return
+16.29%
5 Year Return
+18.04%
10 Year Return
+34.8%
AUM
$3.82B
AUM Growth
+$3.82B
(+1.8%)
Cap. Flow
+$167M
Cap. Flow
% of AUM
4.37%
Top 10 Holdings %
Top 10 Hldgs %
29.38%
Holding
407
New
72
Increased
84
Reduced
67
Closed
155
Top Buys
| 1 |
Alkermes
ALKS
|
$48.8M |
| 2 |
Supernus Pharmaceuticals
SUPN
|
$45.5M |
| 3 |
NARI
Inari Medical, Inc. Common Stock
NARI
|
$37.9M |
| 4 |
Simply Good Foods
SMPL
|
$34.6M |
| 5 |
Immunovant
IMVT
|
$32.5M |
Top Sells
| 1 |
Rigel Pharmaceuticals
RIGL
|
$113M |
| 2 |
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
|
$92.8M |
| 3 |
Agios Pharmaceuticals
AGIO
|
$38.2M |
| 4 |
Coca-Cola
KO
|
$37M |
| 5 |
argenx
ARGX
|
$27.5M |
Sector Composition
| 1 | Healthcare | 68.75% |
| 2 | Consumer Staples | 10.83% |
| 3 | Consumer Discretionary | 10.27% |
| 4 | Technology | 7.69% |
| 5 | Materials | 0.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
PTC Therapeutics
PTCT
$3.92B
| $213M | 2.68% | 6,962,227 +198,227 | +3% | +$6.06M |
|
|
2
Supernus Pharmaceuticals
SUPN
$2.53B
| $141M | 1.77% | 5,272,000 +1,700,000 | +48% | +$45.5M |
|
3
Neurocrine Biosciences
NBIX
$13.8B
| $135M | 1.69% | 978,488 -45,251 | -4% | -$6.23M |
|
4
Cytokinetics
CYTK
$4.23B
| $112M | 1.41% | 2,065,991 +540,303 | +35% | +$29.3M |
|
5
Incyte
INCY
$16.5B
| $107M | 1.35% | 1,764,000 -423,181 | -19% | -$25.7M |
|
|
6
Immunovant
IMVT
$2.56B
| $89.7M | 1.13% | 3,396,909 +1,232,909 | +57% | +$32.5M |
|
|
7
Agios Pharmaceuticals
AGIO
$2.19B
| $89.7M | 1.13% | 2,079,151 -884,849 | -30% | -$38.2M |
|
|
8
argenx
ARGX
$43.6B
| $86M | 1.08% | 200,000 -64,000 | -24% | -$27.5M |
|
9
Novo Nordisk
NVO
$251B
| $77.7M | 0.98% | 544,000 +144,000 | +36% | +$20.6M |
|
10
Sanofi
SNY
$121B
| $72.8M | 0.92% | 1,500,000 +202,000 | +16% | +$9.8M |
|
|
11
Alkermes
ALKS
$4.78B
| $65.1M | 0.82% | 2,699,179 +2,026,961 | +302% | +$48.8M |
|
12
Medtronic
MDT
$119B
| $64.9M | 0.82% | 824,511 +192,152 | +30% | +$15.1M |
|
13
Aurinia Pharmaceuticals
AUPH
$1.58B
| $63.6M | 0.8% | 11,136,000 -1,124,000 | -9% | -$6.42M |
|
14
Travere Therapeutics
TVTX
$1.56B
| $61.7M | 0.78% | 7,500,000 | – | – |
|
15
Exact Sciences
EXAS
$8.98B
| $59.2M | 0.74% | 1,400,086 +669,438 | +92% | +$28.3M |
|
16
GSK
GSK
$79.9B
| $57.8M | 0.73% | 1,500,000 +536,000 | +56% | +$20.6M |
|
17
Dentsply Sirona
XRAY
$2.85B
| $57.2M | 0.72% | 2,298,000 +550,945 | +32% | +$13.7M |
|
18
Shake Shack
SHAK
$4.27B
| $52.2M | 0.66% | 579,904 +236,950 | +69% | +$21.3M |
|
19
PENN Entertainment
PENN
$2.95B
| $51.2M | 0.64% | 2,643,060 +1,266,023 | +92% | +$24.5M |
|
20
Ironwood Pharmaceuticals
IRWD
$214M
| $50.9M | 0.64% | 7,800,000 +2,400,000 | +44% | +$15.6M |
|
21
Grifois
GRFS
$6.78B
| $49.8M | 0.63% | 7,892,000 +1,244,000 | +19% | +$7.84M |
|
22
Orthofix Medical
OFIX
$592M
| $49.7M | 0.63% | 3,750,000 +50,000 | +1% | +$663K |
|
23
Keurig Dr Pepper
KDP
$39.5B
| $49.6M | 0.62% | 1,486,063 +966,924 | +186% | +$32.3M |
|
24
AB InBev
BUD
$122B
| $48.8M | 0.61% | 839,000 +137,000 | +20% | +$7.97M |
|
|
NARI
25
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $48.6M | 0.61% | 1,009,252 +786,501 | +353% | +$37.9M |
|